Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Siemens Healthineers AGLTS:0PMJ -0.88%79 5-Year Yield-on-Cost % is 3.32 as of Aug. 03, 2026, which is 46% above its 10-year median of 2.27. GuruFocus rates LTS:0PMJ with a GF Score™ of 79/100 and a GF Value™ of €52.41 (Significantly Undervalued). The stock has 4 warning signs investors should review. Among 318 Medical Devices & Instruments companies, Siemens Healthineers AG ranks better than 60.69% on this metric.
The historical rank and industry rank for Siemens Healthineers AG's 5-Year Yield-on-Cost % or its related term are showing as below:
LTS:0PMJ'
s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 1.47 Med: 2.27 Max: 5.38
Current: 3.32
During the past 11 years, Siemens Healthineers AG's highest Yield on Cost was 5.38. The lowest was 1.47. And the median was 2.27.
LTS:0PMJ's 5-Year Yield-on-Cost % is ranked better than 60.69% of 318
companies
in the Medical Devices & Instruments industry
Industry Median: 2.435
vs LTS:0PMJ: 3.32
Siemens Healthineers AG (LTS:0PMJ) 5-Year Yield-on-Cost % Explanation
Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.
Siemens Healthineers AG 5-Year Yield-on-Cost % Related Terms
LTS:0PMJ vs ABT, SYK, MDT: 5-Year Yield-on-Cost % Comparison
For the Medical Devices subindustry, Siemens Healthineers AG's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Siemens Healthineers AG 5-Year Yield-on-Cost % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Siemens Healthineers AG's 5-Year Yield-on-Cost % distribution charts can be found below:
* The bar in red indicates where Siemens Healthineers AG's 5-Year Yield-on-Cost % falls into.
Siemens Healthineers AG 5-Year Yield-on-Cost % Calculation
Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.
Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.
Siemens Healthineers AG (LTS:0PMJ) has a 5-Year Yield-on-Cost % of 3.32 as of Aug. 03, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Siemens Healthineers AG and its competitors. This is 46% above median its historical median of 2.27. Over the past decade, Siemens Healthineers AG's 5-Year Yield-on-Cost % has ranged from 1.47 to 5.38. According to the industry distribution chart, Siemens Healthineers AG ranks #125 out of 318 companies in the Medical Devices & Instruments industry, placing it in the top 39.3%.
Is Siemens Healthineers AG's 5-Year Yield-on-Cost % too high?
Siemens Healthineers AG's current 5-Year Yield-on-Cost % of 3.32 is 46% above median its 10-year median of 2.27. Over the past 10 years, this metric has ranged from a low of 1.47 to a high of 5.38. The Medical Devices & Instruments industry median 5-Year Yield-on-Cost % is 2.44. Siemens Healthineers AG's value of 3.32 is 36.3% above this industry median. Based on the distribution chart, Siemens Healthineers AG ranks #125 out of 318 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Siemens Healthineers AG has a GF Score™ of 79/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Siemens Healthineers AG's 5-Year Yield-on-Cost % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Siemens Healthineers AG ranks #125 out of 318 companies for 5-Year Yield-on-Cost %. This puts Siemens Healthineers AG in the upper half of its industry. The industry median 5-Year Yield-on-Cost % is 2.44. Siemens Healthineers AG's value of 3.32 is 36.3% above this benchmark. Historically, Siemens Healthineers AG's own 5-Year Yield-on-Cost % has ranged from 1.47 to 5.38 over the past decade. While the company's 10-year median is 2.27 vs. the industry median of 2.44, Siemens Healthineers AG has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a Medical Devices & Instruments company?
The median 5-Year Yield-on-Cost % among Medical Devices & Instruments companies is 2.44, based on 318 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Siemens Healthineers AG's current 5-Year Yield-on-Cost % of 3.32 is 36.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Siemens Healthineers AG and its competitors. For the Medical Devices & Instruments industry, the median 5-Year Yield-on-Cost % is 2.44 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Siemens Healthineers AG's current 5-Year Yield-on-Cost % is 3.32, which is 46% above median its own 10-year median of 2.27. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Siemens Healthineers AG stock overvalued right now?
Based on GuruFocus' analysis, Siemens Healthineers AG (LTS:0PMJ) is currently considered Significantly Undervalued. The stock's GF Value™ is €52.41, compared to a current price of €36.86 — trading 29.7% below its estimated fair value. The current 5-Year Yield-on-Cost % is 3.32, which is 46% above median its 10-year median of 2.27 and 36.3% above the Medical Devices & Instruments industry median of 2.44. Siemens Healthineers AG's overall GF Score™ is 79/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For Siemens Healthineers AG (LTS:0PMJ), the current 5-Year Yield-on-Cost % is 3.32 as of Aug. 03, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Siemens Healthineers AG (LTS:0PMJ) Overvalued in 2026?
Based on GuruFocus' analysis, Siemens Healthineers AG stock appears to be undervalued.
The current stock price of €36.86 is trading 29.7% below its estimated GF Value™ of €52.41.
GuruFocus considers Siemens Healthineers AG to be Significantly Undervalued.
Key valuation signals for LTS:0PMJ:
5-Year Yield-on-Cost %: 3.32 (46% above median its 10-year median of 2.27)
GF Value™: €52.41 vs. price of €36.86 (29.7% below fair value)
Industry Position: 36.3% above the Medical Devices & Instruments median (#125 of 318)
No single metric tells the full story. See the LTS:0PMJ stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Siemens Healthineers is engaged in therapeutic imaging, radiotherapy, laboratory, and point-of-care diagnostics. The imaging segment (56% of sales in fiscal 2025) includes magnetic resonance imaging, computed tomography, X-ray systems, molecular imaging, and ultrasound. The Varian segment (18% of sales) offers radiotherapy and other oncology solutions. The diagnostics segment (19%) includes in vitro diagnostics and point-of-care diagnostics. The advanced therapies (now part of precision therapy) segment (9%) products are designed to support image-guided minimally invasive treatments in cardiology, interventional radiology, and surgery. The Americas represents 44% of total sales, Europe, Middle East, and Africa 32%, and Asia-Pacific, including China (11%), the remainder.
79GF Score
Get the complete analysis for LTS:0PMJ
5-Year Yield-on-Cost % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LTS:0PMJ has been successfully added to your 
